Search for: "Pfizer Pharmaceutic, Inc."
Results 481 - 500
of 667
Sort by Relevance
|
Sort by Date
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
19 Oct 2009, 4:30 am
Pfizer, Inc., 381 F. [read post]
14 Oct 2009, 12:31 pm
The consent order requires Pfizer to sell approximately half of Wyeth’s Fort Dodge U.S. animal health business, including vaccines for cattle, dogs, and cats, and other pharmaceutical products used in treating cattle, dogs, cats, and horses, to Boehringer Ingelheim Vetmedica, Inc. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
14 Oct 2009, 6:26 am
Pfizer's Acquisition of Wyeth Clears Antitrust HurdlesThis posting was written by Jeffrey May, Editor of CCH Trade Regulation Reporter.Pfizer, Inc.'s proposed $68 billion acquisition of Wyeth was conditionally approved by the Federal Trade Commission (FTC) today. [read post]
9 Oct 2009, 9:11 am
Actavis Elizabeth LLC, Anchen Pharmaceuticals Inc. and Anchen Incorporated (patent infringement) 10/6: Pfizer Inc., Pfizer Pharmaceuticals LLC, Pfizer Ireland Pharmaceuticals, Pfizer Limited and CP Pharmaceuticals International CV v. [read post]
8 Oct 2009, 12:37 pm
Pfizer, Inc. v. [read post]
30 Sep 2009, 12:29 am
Wyeth Pharmaceuticals Inc., 040406301, Court of Common Pleas, Philadelphia County, Pennsylvania. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
24 Sep 2009, 5:09 am
Bieffe USA, Inc., 35 F. [read post]
17 Sep 2009, 4:30 am
Medtronic, Inc., 128 S. [read post]
15 Sep 2009, 10:54 pm
The Takeda case [Takeda Pharmaceutical Co. v. [read post]
11 Sep 2009, 10:33 am
Most of these documents were made public as a result of lawsuits against the following pharmaceutical companies: Merck & Co.; Parke-Davis; Warner-Lambert; and, Pfizer. [read post]
10 Sep 2009, 8:48 am
Pharmaceutical company Pfizer Inc. will pay $2.3 billion to the federal and state governments over allegations that it illegally marketed several drugs for off-label uses, the New York Times reported Sept. 2. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs) Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
8 Sep 2009, 4:00 am
As written by the Associated Press, the huge fine levied last week against Pfizer is unlikely to stop pharmaceutical companies from the profitable practice of off-label marketing of prescription drugs. [read post]
